CDK2 and cancer: In the setting of TNBC and cyclin E/CDK2 expression, our current findings reinforce the critical relationship between repression of non-canonical Smad3 mediated CDK phosphorylation, repression of myc, and increased expression of cdki p15 to facilitate decreased cancer cell viability and increased cell death.